Article
Combination of radiosensitivity index and PD-L1 status predicts overall survival of endometrial cancer patients treated with radiotherapy: A study based on TCGA data
2024-10-29
Abstract excerpt
Identifying biomarker for the clinical outcome of patients with endometrial cancer (EC) after radiotherapy is helpful to optimize treatment. The predictive efficacy of the combination of radiosensitivity index (RSI) and programmed cell death ligand 1 (PD-L1) should be investigated. The endometrial cancer cohort contained 225 patients received radiotherapy, and 285 patients who did not receive radiotherapy was down...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8406c5d5-13b0-5afd-b62a-578ec885c3c4
- DOI
- 10.1101/2024.10.27.24316237
